Cardiology

Your Article Summary

See Latest Articles

Opportunities in pulmonary valve replacement
Expert Review of Cardiovascular Therapy , 09/25/09

Oosterhof T et al. – Owing to the higher risk of thromboembolic events in mechanical prosthesis and the lifetime need for anticoagulation, allografts are the most widely used prosthesis. Degradation of the allograft often leads to reoperation, mostly 10–20 years after initial implantation. For a patient receiving his first allograft at 20 years of age, several reoperations will have to be performed later in life. Percutaneous pulmonary valve implantation has the potential to decrease the number of surgical reoperations.

Today in Cardiac Surgery...keeping you current

Receive free subspecialty "5-minute updates" via email

Statin use and neurologic morbidity after coronary artery bypass grafting. A cohort study
Neurology, 11/18/09

Comparison of Two-Year Outcomes in Patients Undergoing Isolated Coronary Artery Bypass Grafting With and Without Peripheral Artery Disease
The American Journal of Cardiology, 11/09/09

On-Pump versus Off-Pump Coronary-Artery Bypass Surgery
New England Journal of Medicine, 11/05/09

See All of Cardiac Surgery

Today in Valvular Disease...keeping you current

Receive free subspecialty "5-minute updates" via email

Comparison of Cardiac Computed Tomographic Angiography to Transesophageal Echocardiography for Evaluation of Patients With Native Valvular Heart Disease
The American Journal of Cardiology, 11/09/09

Comparison of Safety of Subcutaneous Enoxaparin as Outpatient Anticoagulation Bridging Therapy in Patients With a Mechanical Heart Valve Versus Patients With Nonvalvular Atrial Fibrillation
The American Journal of Cardiology, 11/09/09

Evaluation of Patients With Severe Symptomatic Aortic Stenosis Who Do Not Undergo Aortic Valve Replacement
Circulation: Cardiovascular Quality and Outcomes, 11/20/09

See All of Valvular Disease